Regular use of commonly prescribed painkillers can increase the risk of a heart attack as early as in the first week of use and especially within the first month of taking high doses, suggests a study.
The use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat pain and inflammation can increase the risk of a heart attack from about 20 to 50 per cent, the researchers warned.
The study, published in the journal The BMJ, found that taking any dose of NSAIDs -- such as ibuprofen, diclofenac, celecoxib and naproxen-- for one week, one month or more than a month was associated with an increased risk of heart attack.
"Given that the onset of risk of acute myocardial infarction occurred in the first week and appeared greatest in the first month of treatment with higher doses, prescribers should consider weighing the risks and benefits of NSAIDs before instituting treatment, particularly for higher doses," said Michele Bally from the University of Montreal.
For their study, the researchers carried out a systematic review and a meta-analysis and analysed results on 446,763 people of whom 61,460 had a heart attack.
--IANS
rt/ruwa/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
